Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mohamed M Elmazar (Mohey Elmazar, M M Elmazar)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Molecularly Imprinted

Multidrug Resistant

Top Venues

Scientific reports

International journal of nanomedicine

Turkish journal of pharmaceutical sciences

Drug design, development and therapy

British University in Egypt

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

British University in Egypt Sep 1o 2012

Egypt

Prof of Pharmacology & Founding Dean :: Faculty of Pharmacy

Education History

University of London Dec 10o 1974 - Sep 10o 1978

United Kingdom

PHD :: Pharmacology, Guy's Hospital Medical School

Publications

Rania M Yehia, Dalia A Attia, Mohamed M Elmazar, Mohamed A El-Nabarawi, Mahmoud Hassan Teaima
Screening of Adapalene Microsponges Fabrication Parameters with Insight on the In vitro Biological Effectiveness. Drug design, development and therapy 16 (2022)
Christina Medhat Naiim, Mohamed M Elmazar, Nagwa Ali Sabri, Naglaa Samir Bazan
Extended infusion of piperacillin-tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study. Scientific reports 12 (1) (2022)
Samar A Salim, Elbadawy A Kamoun, Stephen Evans, Shahira Hussainy El-Moslamy, Esmail M El-Fakharany, Mohamed M Elmazar, A F Abdel-Aziz, Radwa H Abou-Saleh, Taher A Salaheldin
Mercaptopurine-Loaded Sandwiched Tri-Layered Composed of Electrospun Polycaprolactone/Poly(Methyl Methacrylate) Nanofibrous Scaffolds as Anticancer Carrier with Antimicrobial and Antibiotic Features: Sandwich Configuration Nanofibers, Release Study and in vitro Bioevaluation Tests. International journal of nanomedicine 16 (2021)
Hebatallah A Wagdy, Mohamed Tarek, Ahmed Amer, Menna Gamal, Mohamed M Elmazar
A Validated Reverse Phase-Ultra-Performance Liquid Chromatography Method for the Determination of Gemifloxacin Mesylate in Bulk and its Pharmaceutical Preparation. Turkish journal of pharmaceutical sciences 16 (1) (2018)